CLINICAL_TRIALS
trial_result
· 2019-10-04
Clinical Trial Update: A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) [Phase 2]
Summary
Phase 2 study evaluating oral VT-1161 for recurrent vulvovaginal candidiasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Viamet | Conditions: Recurrent Vulvovaginal Candidiasis | Phase 2 | Status: COMPLETED | Results posted: 2019-10-04